Cannell & Co. Alector, Inc. Transaction History

Cannell & Co.

$3.01 Billion
Q4 2023

A detailed history of Cannell & Co. transactions in Alector, Inc. stock. As of the latest transaction made, Cannell & Co. holds 66,177 shares of ALEC stock, worth $325,590. This represents 0.02% of its overall portfolio holdings.

Number of Shares

66,177

Previous 88,252 25.01%

Holding current value

$325,590

Previous $571,000 7.53%

% of portfolio

0.02%

Previous 0.02%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 05, 2024	SELL	$3.77 - $8.39 $83,222 - $185,209	-22,075 Reduced 25.01%	66,177 $528,000
Q3 2023 Nov 14, 2023	SELL	$5.2 - $8.77 $114,530 - $193,159	-22,025 Reduced 19.97%	88,252 $571,000
Q1 2023 May 08, 2023	SELL	$5.85 - $9.84 $16,350 - $27,502	-2,795 Reduced 2.47%	110,277 $682,000
Q4 2022 Feb 03, 2023	SELL	$6.88 - $9.55 $6,880 - $9,550	-1,000 Reduced 0.88%	113,072 $1.04 Million
Q3 2022 Nov 02, 2022	SELL	$8.19 - $13.2 $165,438 - $266,640	-20,200 Reduced 15.04%	114,072 $1.08 Million
Q1 2022 May 10, 2022	SELL	$13.02 - $20.78 $4,231 - $6,753	-325 Reduced 0.24%	134,272 $1.91 Million
Q4 2021 Feb 09, 2022	SELL	$19.35 - $25.54 $10,158 - $13,408	-525 Reduced 0.39%	134,597 $2.78 Million
Q3 2021 Nov 10, 2021	SELL	$21.65 - $39.49 $194,850 - $355,410	-9,000 Reduced 6.24%	135,122 $3.08 Million
Q2 2021 Aug 09, 2021	SELL	$15.5 - $22.48 $3,100 - $4,496	-200 Reduced 0.14%	144,122 $3 Million
Q1 2021 May 07, 2021	SELL	$14.84 - $22.23 $291,902 - $437,264	-19,670 Reduced 11.99%	144,322 $2.91 Million
Q4 2020 Feb 11, 2021	SELL	$9.4 - $16.7 $43,240 - $76,820	-4,600 Reduced 2.73%	163,992 $2.48 Million
Q3 2020 Nov 12, 2020	SELL	$10.54 - $24.96 $416,856 - $987,168	-39,550 Reduced 19.0%	168,592 $1.78 Million
Q2 2020 Aug 07, 2020	SELL	$21.87 - $33.11 $176,119 - $266,634	-8,053 Reduced 3.72%	208,142 $5.09 Million
Q1 2020 May 05, 2020	BUY	$16.25 - $35.28 $1.62 Million - $3.53 Million	99,945 Added 85.97%	216,195 $5.22 Million
Q4 2019 Feb 10, 2020	BUY	$14.17 - $20.3 $327,681 - $469,437	23,125 Added 24.83%	116,250 $2 Million
Q3 2019 Nov 12, 2019	BUY	$14.42 - $22.2 $299,575 - $461,205	20,775 Added 28.71%	93,125 $1.34 Million
Q2 2019 Aug 12, 2019	BUY	$16.26 - $26.42 $1.18 Million - $1.91 Million	72,350 New	72,350 $1.38 Million

Others Institutions Holding ALEC

# of Institutions

165

Shares Held

58.1M

Call Options Held

57K

Put Options Held

14.9K

View Full List

About Alector, Inc.

Ticker ALEC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 82,563,904
Market Cap $406M
Description
Alector, Inc., a clinical stage biopharmaceutical company, develops therapies for the treatment of neurodegeneration diseases. Its products include AL001, a humanized recombinant monoclonal antibody, which is in Phase III clinical trial for the treatment of frontotemporal dementia, Alzheimer's, Parkinson's, and amyotrophic lateral sclerosis dise...

More about ALEC

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Cannell & Co., based on Form 13F filings with the SEC.

News

Stay updated on Cannell & Co. with notifications on news.

Account